Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2022-06-24 00:00:00 ET · period of report 2022-06-22 · accession 0000899243-22-023987 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-24 | 2022-06-22 | TCRT | Postma Robert W | Dir | A - Grant | $0.00 | +40.0K | 1.24M | +3% | $0 |
| D | 2022-06-24 | 2022-06-22 | TCRT | Postma Robert W | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-22 | A | A | 40,000 | $0.00 | 1,241,870 | D | — | — | (F1) Includes 946,970 shares of common stock underlying units of the Issuer (the "Units"). Each Unit is comprised of one share of common stock and one warrant to acquire one share of common stock. The Reporting Person previously purchased 946,970 Units in a private placement transaction with the Issuer. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-06-22 | A | A | 100,000 | $0.00 | 100,000 | D | $0.82 · — to 2032-06-21 | 100,000 Common Stock | (F3) The option vests in twelve equal monthly installments beginning on July 13, 2022. |